Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Forbes

Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered

Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered
ShareXFacebook

GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.

F

Source

Forbes

Read full article at Forbes

Opens original article in a new tab

Advertisement

Related Economy Stories

Paz Says Protests Test Democracy Ahead of Talks
Bloomberg Markets

Paz Says Protests Test Democracy Ahead of Talks

Bolivia President Rodrigo Paz tells Wall Street Week why pragmatism — not ideology — will define his government, and why closing the chapter on 20 years of one-party rule won’t be easy. (Source: Bloomberg)

Read more →
Advertisement